Zhongnan Medical Journal Press

Home Results

A total of 31 result was found. Results that relate to Type 2 diabetes

Meta-analysis of the efficacy of oral probiotics in adults with type 2 diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2023,32(1):60-71.
5750 times 2146 times

Yun-Jie TENG Ying-Hong WANG Jing CHEN Ming-Chen ZHANG

Probiotics Type 2 diabetes Adults Meta-analysis Meta-regression Randomized controlled trial
Details
Effects of GLP-1RA therapy in patients with overweight, obese type 2 diabetes mellitus and coronary heart disease

Published on Journal of Mathematical Medicine 2023,36(2):144-149.
7595 times 1707 times

Si-Yuan XIE Zi-Qiang ZHU

Glucagon-like peptide-1 receptor agonist Type 2 diabetes mellitus Coronary heart disease Overweight Obesity Insulin sensitivity
Details
Clinical study of dagglizin combined with metoprolol in the treatment of type 2 diabetes with paroxysmal atrial fibrillation

Published on Chinese Journal of Pharmacoepidemiology 2023,32(6):633-640.
9408 times 1529 times

Mei DONG Xu-Du SUN Shan ZHANG

Dagglizin Metoprolol Type 2 diabetes Paroxysmal atrial fibrillation Atrial elec-trophysiological parameters P wave dispersion
Details
Rapid health technology assessment of dulaglutide for the treatment of type 2 diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2023,32(8):931-940.
7935 times 1788 times

Yuan YAO Fen-Li SU Xu SUN Shi-Yin FENG Fen XIONG Qing-Qun CAI

Dulaglutide Type 2 diabetes mellitus Rapid health technology assessment
Details
Study of the correlation between glycosylated hemoglobin level, insulin resistance index, complications and psychological control sources in type 2 diabetes patients

Published on Journal of Mathematical Medicine 2023,36(6):434-439.
9063 times 1647 times

Wen-Fang LI Jing XIN Xin-Feng HOU Ya-Fei SHEN Fei DENG

Type 2 diabetes mellitus Psychological control source Glycosylated hemoglobin Insulin resistance index Complication
Details
Risk factors and prediction model of ketosis tendency in patients with newly diagnosed type 2 diabetes mellitus

Published on Journal of Mathematical Medicine 2023,36(8):586-591.
7170 times 1709 times

Jia-Yao CAI Xue-Jiang GU Yu-Hui PENG

Type 2 diabetes mellitus Newly diagnosed Ketosis tendency Risk factor Prediction model
Details
Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1275-1284.
7416 times 1813 times

Ya-Ping NIU San-Bao CHAI Jing-Zi MA Meng ZHANG Zuo-Xiang LIU Shan-Shan WU Feng SUN

Basal insulin Oral hypoglycemic agents Type 2 diabetes mellitus Poor treatment effect Umbrella review
Details
Influences of dapagliflozin on blood pressure variability and left ventricular mass index in patients with type 2 diabetes mellitus and hypertension

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):413-419.
7551 times 2045 times

Sa-Sa LI Bei-Bei YE Xin LIU Xia-Ling ZHU

Dapagliflozin Type 2 diabetes mellitus Hypertension Blood pressure variability Left ventricular mass index
Details
Analysis of medication and glycemic control of patients with type 2 diabetes under chronic disease management in Xi’an pharmacies

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):184-193.
9406 times 1791 times

ZHU Xiaoying REN Biqi SU Xinyue LEI Shuang LIN Shuzhi LIU Wei FENG Bianling

Type 2 diabetes Medication Blood glucose control Chronic disease management
Details
Study on the potential molecular mechanism of Ziyabiti tablets on type 2 diabetes based on network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):192-198.
8473 times 3007 times

Maimaiti Simayi Aizezijiang Aierken HU Yan Wusiman Aihaiti

Ziyabiti tablets Type 2 diabetes Network pharmacology Molecular mechanism Quercetin Kaempferol
Details
Study on the application effect of metformin combined with information-motivation-behavioral model intervention in patients with type 2 diabetes

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):431-439.
9195 times 1999 times

YU Li WANG Xiarong ZHANG Huabei WU Huan YIN Qiong HU Liuqing ZHOU Hongyu

Type 2 diabetes Metformin treatment Information-motivation-behavioral model intervention Satisfaction
Details
The efficacy and safety of liraglutide combined with acarbose in the treatment of obese type 2 diabetes mellitus: a meta-analysis

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):491-500.
8834 times 1493 times

WANG Zhengdong WU Wei ZHOU Aiming

Liraglutide Acarbose Obesity type 2 diabetes Randomized controlled trial Meta-analysis
Details
Pharmacoeconomic evaluation of glucagon-like peptide-1 receptor agonist combined with metformin in the treatment of type 2 diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):388-401.
10363 times 2443 times

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

Glucagon-like peptide-1 receptor agonist Metformin Type 2 diabetes mellitus Cost-utility Markov model Pharmacoeconomics
Details
Effect of Tanganjianwan combined with abdominal massage on glucose and lipid metabolism and inflammatory factors in patients of metformin treatment with obesity and type 2 diabetes mellitus

Published on Frontiers in Pharmaceutical Sciences 2024,27(4):595-602.
9448 times 2034 times

HU Lijuan WAN Jing ZHU Hao

Tanganjianwan Abdominal massage Obesity and type 2 diabetes mellitus Glucose and lipid metabolism Inflammatory factors
Details
Efficacy and safety of glucagon-like peptide 1 receptor agonists in the treatment of overweight or obese patients with type 2 diabetes: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):519-538.
9172 times 1955 times

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

Glucagon-like peptide 1 receptor agonists Type 2 diabetes mellitus Obesity or overweight Efficacy Safety Meta-analysis Randomized controlled trial
Details